… for Translational Research, a gift from Nuclea Biomarkers to the Jimmy Fund and the Loda
laboratory. Massimo Loda is the recipient of a grant from the Dana Farber Cancer Institute–…

Disclosures: MR Looney reported" other" from Neutrolis outside the submitted work. RE
Schwartz is a Sponsored Advisory Board Member for Miromatrix Inc. JD Spicer reported …

A powerful way to discover key genes with causal roles in oncogenesis is to identify
genomic regions that undergo frequent alteration in human cancers. Here we present high-…

Prostate tumors are among the most heterogeneous of cancers, both histologically and
clinically. Microarray expression analysis was used to determine whether global biological …

With the advent of effective tools to study lipids, including mass spectrometry-based lipidomics,
lipids are emerging as central players in cancer biology. Lipids function as essential …

Somatic mutations in DNA mismatch repair genes have been observed in sporadic tumors
as well as cell lines and xenografts derived from such tumors implicating genetic defects of …

Loss of PTEN function leads to activation of phosphoinositide 3-kinase (PI3K) signaling and
Akt. Clinical trials are now testing whether mammalian target of rapamycin (mTOR) inhibition …

The evolution of prostate cancer from an androgen-dependent state to one that is androgen-independent
marks its lethal progression. The androgen receptor (AR) is essential in both, …

The anemia of chronic disease is a prevalent, poorly understood condition that afflicts patients
with a wide variety of diseases, including infections, malignancies, and rheumatologic …

Heterogeneity in the genomic landscape of metastatic prostate cancer has become apparent
through several comprehensive profiling efforts, but little is known about the impact of this …